Skip to main content
. 2025 May 20;17:163. doi: 10.1186/s13098-025-01728-2

Table 2.

Association of echocardiographic variables for various glucose variation measures in patients with type 2 diabetes using observational epidemiologic approach (n = 2326)

FPG-CV per 1 SD HbA1c-CV per 1 SD
Model 1 Mode 2 Model 3 Model 1 Mode 2 Model 3
Echocardiographic variables β (SE) R2 β (SE) R2 β (SE) R2 β (SE) R2 β (SE) R2 β (SE) R2
Cardiac structural parameters
 LAD (mm) 0.36 (0.12)** 0.02 0.52 (0.13)*** 0.13 0.42 (0.13)** 0.14 0.16 (0.12) 0.01 0.35 (0.13)** 0.12 0.32 (0.13)* 0.14
 LVDd (mm) 0.11 (0.12) 0.07 0.26 (0.13)* 0.10 0.18 (0.13) 0.12 -0.01 (0.12) 0.07 0.12 (0.13) 0.10 0.10 (0.13) 0.12
 LVSd (mm) 0.44 (0.11)*** 0.06 0.45 (0.13)*** 0.08 0.39 (0.13)** 0.09 0.23 (0.11)* 0.06 0.21 (0.13) 0.07 0.20 (0.13) 0.09
 LVM (g) 3.52 (0.81)*** 0.09 4.69 (0.87)*** 0.16 4.02 (0.87)*** 0.19 0.54 (0.82) 0.09 1.33 (0.88) 0.15 1.17 (0.87) 0.19
Cardiac systolic function
 LVEF (%) -0.98 (0.17)*** 0.03 -0.79 (0.18)*** 0.04 -0.74 (0.19)*** 0.06 -0.61 (0.17)*** 0.02 -0.34 (0.19) 0.04 -0.36 (0.19) 0.05
Cardiac diastolic function
 E 0.02 (0.004)*** 0.03 0.02 (0.004)*** 0.05 0.02 (0.004)*** 0.06 0.00 (0.004) 0.02 0.01 (0.004) 0.04 0.01 (0.004) 0.05
 e’ -0.16 (0.04)*** 0.18 -0.08 (0.04)* 0.20 -0.06 (0.04) 0.22 -0.12 (0.04)*** 0.17 -0.05 (0.04) 0.20 -0.05 (0.04) 0.22
 s’ -0.05 (0.03) 0.11 0.01 (0.04) 0.12 0.02 (0.04) 0.13 -0.01 (0.03) 0.10 0.03 (0.04) 0.12 0.03 (0.04) 0.13
 E/A ratio 0.00 (0.01) 0.08 0.00 (0.01) 0.09 0.00 (0.01) 0.10 0.00 (0.01) 0.08 0.01 (0.01) 0.09 0.01 (0.01) 0.10
 E/e’ ratio 0.63 (0.09)*** 0.14 0.48 (0.09)*** 0.18 0.39 (0.09)*** 0.20 0.33 (0.09)*** 0.13 0.23 (0.09)* 0.17 0.21 (0.09)* 0.20
 Deceleration time (msec) -4.33 (1.20)*** 0.05 -4.16 (1.34)** 0.06 -4.41 (1.36)** 0.07 -3.19 (1.21)** 0.05 -2.93 (1.35)* 0.06 -3.04 (1.36)* 0.06

Multivariate model 1 adjusted for age and sex

Multivariate model 2 adjusted for life style behaviors, diabetes-related variables, HbA1c and FPG in addition to age and sex in multivariate model 1

Multivariate model 3 adjusted for baseline status of complications and medicines use in addition to the variables in the multivariate model 2

*: p < 0.05; **:p < 0.01; ***:p < 0.001